PAUPAR regulates PAX6 proper binding to the target neural genes. (A) Average profiles of PAX6 enrichment in genome-wide level of control and PAU-PAKI cells on day 16 of dorsal neural differentiation. (B) PAX6 binding motif in control and PAU-PAKI cells on day 16 of dorsal neural differentiation. (C) Genome-wide heatmaps of PAX6 enrichment of target genes in control and PAU-PAKI cells on day 16 of dorsal neural differentiation. (D) Analysis of significant GO terms in PAX6 binding diminished genes. (E) Genome browser screenshots of PAX6 ChIP-seq on SOX1, POU3F3, MSX1 and NR2F1 in control and PAU-PAKI cells on day 16 of dorsal neural differentiation. (F) Enrichment of PAX6 on SOX1 (TSS +1300), POU3F3 (TSS +1000), MSX1 (TSS +1000) and NR2F1 (TSS +1500) genomic region in control and PAU-PAKI cells on day 16 of dorsal neural differentiation. (G) Enrichment of PAX6 on TBR1 (TSS +200) and TBR2 (TSS –1000) genomic region in control and PAU-PAKI cells on day 25 of dorsal neural differentiation. (H, I) Enrichment of PAX6 on SOX1 (TSS +1300), POU3F3 (TSS +1000), MSX1 (TSS +1000) and NR2F1 (TSS +1500) genomic region after PAUPAR overexpression in the PAU-PAKI cells on day 16 (H), TBR1 (TSS +200) and TBR2 (TSS -1000) genomic region on day 25 (I) of dorsal neural differentiation. Data are presented as mean ± SEM. *P< 0.05, **P< 0.01, ***P< 0.001 versus CTRL group (F–I); #P< 0.05, ##P< 0.01, ###P< 0.001 versus PAU-PAKI + ptPAU-dox group (H and I) (t-test). See also Supplementary Figure S4.